Literature DB >> 20671880

Factor V Leiden in Chioggia: a prevalence study in patients with venous thrombosis, their blood relatives and the general population.

Gianluca Gessoni1, Sara Valverde, Rosa Canistro, Fabio Manoni.   

Abstract

Entities:  

Keywords:  FVL; family study; general population; risk factor; thrombosis

Mesh：

Substances：

Year:  2010        PMID： 20671880      PMCID： PMC2906187          DOI： 10.2450/2010.0157-09

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  10 in total

1.  Screening for activated protein C resistance before oral contraceptive treatment: a pilot study.

Authors:  G Palareti; C Legnani; M Frascaro; C Flamigni; L Gammi; G Gola; G Fuschini; S Coccheri
Journal:  Contraception       Date:  1999-05       Impact factor: 3.375

2.  Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

Authors:  Paolo Simioni; Daniela Tormene; Paolo Prandoni; Patrizia Zerbinati; Sabrina Gavasso; Philip Cefalo; Antonio Girolami
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

3.  Incidence of venous thromboembolism in families with inherited thrombophilia.

Authors:  P Simioni; B J Sanson; P Prandoni; D Tormene; P W Friederich; B Girolami; S Gavasso; M V Huisman; H R Büller; J Wouter ten Cate; A Girolami; M H Prins
Journal:  Thromb Haemost       Date:  1999-02       Impact factor: 5.249

Review 4.  Inherited thrombophilia, pregnancy, and oral contraceptive use: clinical implications.

Authors:  Valerio De Stefano; Elena Rossi; Giuseppe Leone
Journal:  Semin Vasc Med       Date:  2003-02

5.  Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.

Authors:  Gianluca Gessoni; Sara Valverde
Journal:  Blood Coagul Fibrinolysis       Date:  2007-10       Impact factor: 1.276

Review 6.  Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.

Authors:  Jodi B Segal; Daniel J Brotman; Alejandro J Necochea; Ashkan Emadi; Lipika Samal; Lisa M Wilson; Matthew T Crim; Eric B Bass
Journal:  JAMA       Date:  2009-06-17       Impact factor: 56.272

7.  Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.

Authors:  G Gessoni; S Valverde; R Canistro; E Trabuio; F Antico; F Manoni
Journal:  Minerva Med       Date:  2007-04       Impact factor: 4.806

Review 8.  Epidemiology of factor V Leiden: clinical implications.

Authors:  V De Stefano; P Chiusolo; K Paciaroni; G Leone
Journal:  Semin Thromb Hemost       Date:  1998       Impact factor: 4.180

Review 9.  Screening for inherited thrombophilia: indications and therapeutic implications.

Authors:  Valerio De Stefano; Elena Rossi; Katia Paciaroni; Giuseppe Leone
Journal:  Haematologica       Date:  2002-10       Impact factor: 9.941

10.  [Thrombophilia risk factors evaluation in a group of Italian patients with deep venous thrombosis].

Authors:  Sara Valverde; Francesco Antico; Ernesto Trabuio; Daniela Basso; Filippo Navaglia; Elisa Orlandini; Alda Giacomini; Fabio Manoni; Gianluca Gessoni
Journal:  Recenti Prog Med       Date:  2008 Jul-Aug
  10 in total
  5 in total

1.  GeneXpert in the diagnosis of risk factors for thrombophilia: evaluation of its use in a small laboratory.

Authors:  Gianluca Gessoni; Sara Valverde Sara; Rosa Canistro; Fabio Manoni
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

2.  The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden.

Authors:  Gianluca Gessoni; Sara Valverde; Francesca Gessoni; Roberto Valle
Journal:  Blood Transfus       Date:  2015-01-29       Impact factor: 3.443

Review 3.  Utility of testing for factor V Leiden.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

4.  Rare Risk Variants Identification by Identity-by-Descent Mapping and Whole-Exome Sequencing Implicates Neuronal Development Pathways in Schizophrenia and Bipolar Disorder.

Authors:  C Salvoro; S Bortoluzzi; A Coppe; G Valle; E Feltrin; M L Mostacciuolo; G Vazza
Journal:  Mol Neurobiol       Date:  2018-02-06       Impact factor: 5.590

5.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.